HCV in Egypt, prevention, treatment and key barriers to elimination-Reference-Cited by-同舟云学术

HCV in Egypt, prevention, treatment and key barriers to elimination

Published:2018-03-11 Issue:4 Volume:16 Page:345-350
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

El Kassas Mohamed¹,Elbaz Tamer²,Elsharkawy Aisha²,Omar Heba²^ORCID,Esmat Gamal²

Affiliation:

1. Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt

2. Endemic Hepatogastroenterology, Faculty of Medicine, Cairo University, Cairo, Egypt

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2018.1448709

Reference41 articles.

1. Ministry of Health, Egypt, El-Zanaty and Associates, Egypt, ICF International. Egypt Health Issues Survey. Cairo, Egypt and Rockville, MD, USA: Ministry of Health and ICF International; 2015.

2. El-Zenati F, Way A. Knowledge and prevalence of Hepatitis C. Egypt demographic and health survey 2008. [ONLINE]. [cited 2017 Oct 10]. Available from: https://dhsprogram.com/pubs/pdf/FR220/FR220.pdf

3. Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors

4. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt

5. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steatotic liver disease as a new nomenclature for NAFLD from the perspectives of the MENA region: One size fits all this time;Journal of Hepatology;2024-02

2. Rare liver diseases in Egypt: Clinical and epidemiological characterization;Arab Journal of Gastroenterology;2024-01

3. Cancer mortality patterns in selected Northern and Southern African countries;European Journal of Cancer Prevention;2023-11-24

4. Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC;BMC Cancer;2023-10-05

5. Vascular Changes in Chronic Hepatitis C Cirrhotic Patients Treated with Direct Acting Antiviral Agents;2022-09-08